{
    "title": "GlaxoSmithKline thinks small",
    "url": "https://www.dailymail.co.uk/money/news/article-1560871/GlaxoSmithKline-thinks-small.html",
    "date": "2001-01-14",
    "keywords": [
        "glaxosmithkline",
        "staff",
        "group",
        "rd",
        "biotech",
        "merger",
        "smithkline",
        "month",
        "research",
        "development",
        "drug",
        "treatment",
        "market",
        "approval",
        "biotechnology",
        "industry",
        "buckingham",
        "gmt",
        "view",
        "executive",
        "signal",
        "giant",
        "buying",
        "message",
        "glaxo",
        "importance",
        "licensing",
        "shift",
        "certainty",
        "pipeline",
        "promising",
        "avandia",
        "sale",
        "glaxos",
        "launch",
        "bowel",
        "lotronex",
        "safety",
        "november",
        "prevention",
        "move",
        "distribution",
        "pfizer",
        "title",
        "partnership",
        "strategy",
        "end",
        "partner",
        "choice",
        "broadcast",
        "effort",
        "fact",
        "bill",
        "area",
        "garnier",
        "idea",
        "hand",
        "company",
        "bureaucracy",
        "approach",
        "period",
        "blockbuster",
        "householdname",
        "zantac",
        "prozac",
        "azt"
    ],
    "category": [
        "money",
        "news"
    ]
}